Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase JAK2 | ||
Ligand | BDBM333122 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Biochemical JAK Kinase Assays | ||
Ki | 0.020±n/a nM | ||
Citation | Long, DD; Smith, C; Thompson, C Dimethyl amino azetidine amides as JAK inhibitors US Patent US11634419 Publication Date 4/25/2023 | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase JAK2 | |||
Name: | Tyrosine-protein kinase JAK2 | ||
Synonyms: | JAK-2 | JAK2 | JAK2_HUMAN | Janus kinase 2 | Janus kinase 2 (JAK2) | Janus kinase 2 (a protein tyrosine kinase) | ||
Type: | Protein | ||
Mol. Mass.: | 130684.68 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O60674 | ||
Residue: | 1132 | ||
Sequence: |
| ||
BDBM333122 | |||
n/a | |||
Name | BDBM333122 | ||
Synonyms: | (S)-(3-(dimethylamino)-3-methylazetidin-1-yl)(2-(6-(2-ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl)-5-propyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-6-yl)methanone | US10196393, Example 8 | US10196393, Example 8-1 | US10196393, Example 8-10 | US10196393, Example 8-11 | US10196393, Example 8-12 | US10196393, Example 8-13 | US10196393, Example 8-15 | US10196393, Example 8-16 | US10196393, Example 8-17 | US10196393, Example 8-18 | US10196393, Example 8-19 | US10196393, Example 8-2 | US10196393, Example 8-20 | US10196393, Example 8-21 | US10196393, Example 8-3 | US10196393, Example 8-4 | US10196393, Example 8-5 | US10196393, Example 8-6 | US10196393, Example 8-7 | US10196393, Example 8-8 | US10196393, Example 8-9 | US10550118, Example 8 | US10947229, Example C-6 | US11453668, Example 8 | US11634419, Example C-6 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H38FN7O2 | ||
Mol. Mass. | 559.6775 | ||
SMILES | CCCN1Cc2[nH]c(nc2C[C@H]1C(=O)N1CC(C)(C1)N(C)C)-c1n[nH]c2cc(ccc12)-c1cc(F)c(O)cc1CC |r| | ||
Structure |